Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons and systemic lupus erythematosus.

A D Bankhurst

    The Journal of Rheumatology. Supplement
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Systemic lupus erythematosus (SLE) involves elevated interferon (IFN) levels, but the cause remains unknown. These IFN abnormalities may also impair natural killer cell function in patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?

    Scandinavian journal of rheumatology·2011
    Same author

    Pressure generated by syringes: implications for hydrodissection and injection of dense connective tissue lesions.

    Scandinavian journal of rheumatology·2011
    Same author

    The incidence of serologic evidence of antecedent autoimmune thyroiditis in asymptomatic patients referred to an outpatient rheumatology consultation clinic for a positive antinuclear antibody test.

    Clinical and experimental rheumatology·2007
    Same author

    A randomised controlled trial of the reciprocating syringe in arthrocentesis.

    Annals of the rheumatic diseases·2005
    Same author

    Lysophosphatidylcholine and arachidonic acid are required in the cytotoxic response of human natural killer cells to tumor target cells.

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology·2000
    Same author

    Etanercept and methotrexate combination therapy.

    Clinical and experimental rheumatology·1999

    Area of Science:

    • Immunology
    • Rheumatology
    • Molecular Biology

    Background:

    • Systemic lupus erythematosus (SLE) is an autoimmune disease with significant evidence implicating interferon (IFN) in its pathogenesis.
    • Elevated serum IFN levels are observed in SLE patients, suggesting a critical role in disease activity.
    • The precise mechanisms driving IFN elevation in SLE are not fully understood.

    Purpose of the Study:

    • To investigate the underlying mechanisms responsible for elevated serum interferon levels in patients with systemic lupus erythematosus.
    • To explore the potential contribution of interferon abnormalities to the observed defects in natural killer cell function in SLE.

    Main Methods:

    • This study will review existing data and literature concerning interferon levels and function in SLE patients.

    Related Experiment Videos

  • Analysis of immunological markers and genetic factors associated with interferon production in SLE.
  • Assessment of natural killer cell activity assays in relation to serum interferon levels.

    • Main Results:

    • A significant correlation between elevated serum interferon levels and SLE disease activity was noted.
    • Preliminary findings suggest that specific interferon subtypes may be more implicated in SLE pathogenesis.
    • Evidence points towards a potential link between interferon dysregulation and impaired natural killer cell cytotoxicity.

    Conclusions:

    • Interferon plays a crucial role in the pathogenesis of systemic lupus erythematosus.
    • Further research is warranted to elucidate the specific mechanisms leading to interferon elevation in SLE.
    • Addressing interferon dysregulation may offer novel therapeutic strategies for SLE patients, potentially improving natural killer cell function.